513 related items for PubMed ID: 23083688
1. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL.
Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
[Abstract] [Full Text] [Related]
2. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[Abstract] [Full Text] [Related]
3. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE, Hagiwara M, Stanford RH, Stempel DA.
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[Abstract] [Full Text] [Related]
4. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
Hagiwara M, Delea TE, Stanford RH.
J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
[Abstract] [Full Text] [Related]
5. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[Abstract] [Full Text] [Related]
6. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L, Forget A, Ramachandran S.
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[Abstract] [Full Text] [Related]
7. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS, Yawn BP.
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[Abstract] [Full Text] [Related]
8. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[Abstract] [Full Text] [Related]
9. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
[Abstract] [Full Text] [Related]
10. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
Tunceli O, Williams SA, Kern DM, Elhefni H, Pethick N, Wessman C, Zhou S, Trudo F.
J Allergy Clin Immunol Pract; 2014 Feb; 2(6):719-26. PubMed ID: 25439363
[Abstract] [Full Text] [Related]
11. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[Abstract] [Full Text] [Related]
12. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA.
Curr Med Res Opin; 2009 Nov; 25(11):2729-35. PubMed ID: 19778165
[Abstract] [Full Text] [Related]
13. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[Abstract] [Full Text] [Related]
14. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Stempel DA, Riedel AA, Carranza Rosenzweig JR.
Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
[Abstract] [Full Text] [Related]
15. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
Allen-Ramey FC, Bukstein D, Luskin A, Sajjan SG, Markson LE.
J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437
[Abstract] [Full Text] [Related]
16. Adherence to asthma controller medication regimens.
Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[Abstract] [Full Text] [Related]
17. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[Abstract] [Full Text] [Related]
18. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
Hagiwara M, Delea TE, Stanford RH, Stempel DA.
Allergy Asthma Proc; 2010 Jun; 31(3):203-10. PubMed ID: 20534183
[Abstract] [Full Text] [Related]
19. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD, Gilmore AS, Manjunath R, Stanford RH, Legorreta AP, Jhingran PM.
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[Abstract] [Full Text] [Related]
20. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
Blais L, Beauchesne MF, Forget A.
Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
